Personalized Medicine Market By Product (PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness) Is Expected To Reach USD 2,452.5 Billion In 2022: Grand View Research, Inc.
Global personalized medicine market is expected to reach USD 2,452.5 billion by 2022; according to a new study by Grand View Research, Inc. Growing number of approved companion diagnostics and biomarkers have aided the development of advanced personalized diagnostic tests and enhanced the level of treatment monitoring for a range of complex diseases. A significant number of diagnostics and therapeutic products, which are currently under clinical development and investigational research, are associated with one or the other proteomic or genomic markers and fall under category of companion diagnostics. Personalized medicine finds extensive and indispensable applications in the field of oncology. Furthermore, a marked technological advancement of next generation sequencing is expected to significantly enhance market usage rates owing to, a considerable decrease in the costs of whole genome sequencing and is expected to improve the demand for personalized medical diagnostic and therapeutic products over the forecast period. Personalized medical care and nutrition accounted for the largest share of the market in 2014 owing to, the presence of a significantly large consumer base, relatively less number of regulatory mandates, and the over-the-counter nature of retail nutrition products. This large share is also due to, the highly capital-intensive nature of implementation of healthcare information technology and telemedicine applications. View summary of this report @ analysis/personalized-medicine-market
http://www.grandviewresearch.com/industry-
Global personalized medicine market, by product, 2012-2022 (USD Billion)
Table of Content Chapter 1 Methodology and Scope 1.1 Research Methodology 1.2 Research Scope & Assumptions 1.3 List of Data Sources Chapter 2 Executive Summary 2.1 Personalized medicine - Industry Snapshot & Key Buying Criteria, 2012 - 2022 Chapter 3 Personalized Medicine Industry Outlook 3.1 Market segmentation 3.2 Market size and growth prospects 3.3 Personalized medicine: Market dynamics 3.3.1 Market driver analysis 3.3.1.1 Advancement of next generation sequencing 3.3.1.2 Growing number of companion/associated diagnostics 3.3.1.3 Increasing number of retail clinics across the developed regions of North America and Europe 3.3.1.4 Increasing prevalence of cancer 3.3.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer 3.3.1.6 Increasing usage of biomarkers for PM cancer therapy 3.3.2 Market restraint analysis 3.3.2.1 Presence of non value-based PM diagnostics reimbursement policy 3.3.2.2 Burden of proof is greater for clinical validation for PM therapeutics
3.3.2.3 Lack of proper intellectual property regulations for personalized medical technologies 3.3.2.4 Non-structural development of biomarkers 3.4 Key Opportunities Prioritized 3.4.1 Key Opportunities Prioritized - PM Diagnostics & PM Therapeutics 3.4.2 Key Opportunities Prioritized - PM Medical Care & PM Nutrition 3.5 Industry analysis - Porter’s 3.6 Personalized medicine - PESTEL Analysis 3.7 Personalized Medicine - Application Growth Prospects Analysis 3.7.1 Personalized medicine - application opportunity v/s implementation 3.7.2 Personalized Medicine- Application Opportunities Prioritized Chapter 4 Personalized Medicine Product Outlook 4.1 Global personalized medicine revenue share, by product, 2014 & 2022 4.2 PM diagnostics 4.2.1 PM diagnostics market, 2012 - 2022 (USD Billion) 4.2.2 Genetic testing 4.2.2.1 Genetic testing market, 2012 - 2022 (USD Billion) 4.2.3 Direct-to-consumer (DTC) diagnostics 4.2.3.1 DTC diagnostics market, 2012 - 2022 (USD Billion) 4.2.4 Esoteric lab services 4.2.4.1 Esoteric lab services market, 2012 - 2022 (USD Billion) 4.2.5 Esoteric lab tests 4.2.5.1 Esoteric lab tests market, 2012 - 2022 (USD Billion) 4.3 PM therapeutics 4.3.1 PM therapeutics market, 2012 - 2022 (USD Billion) 4.3.2 Pharmaceuticals 4.3.2.1 Pharmaceuticals market, 2012 - 2022 (USD Billion) 4.3.3 Genomic medicine 4.3.3.1 Genomic medicine market, 2012 - 2022 (USD Billion) 4.3.4 Medical devices 4.3.4.1 Medical devices market, 2012 - 2022 (USD Billion) 4.4 Personalized medical care 4.4.1 Personalized medical care market, 2012 - 2022 (USD Billion) 4.4.2 Telemedicine 4.4.2.1 Telemedicine market, 2012 - 2022 (USD Billion) 4.4.3 Health information technology 4.4.3.1 Health information technology market, 2012 - 2022 (USD Billion) 4.4.4 Disease Management 4.4.4.1 Disease management market, 2012 - 2022 (USD Billion) 4.5 Personalized nutrition & wellness 4.5.1 Personalized nutrition & wellness market, 2012 - 2022 (USD Billion) 4.5.2 Retail nutrition 4.5.2.1 Retail nutrition market, 2012 - 2022 (USD Billion)
4.5.3 Complementary medicine 4.5.3.1 Complementary medicine market, 2012 - 2022 (USD Billion) 4.5.4 Alternative medicine 4.5.4.1 Alternative medicine market, 2012 - 2022 (USD Billion) Chapter 5 Personalized Medicine Regional Outlook 5.1 Global personalized medicine revenue share, by region, 2014 & 2022 5.2 North America 5.2.1 North America personalized medicine market, 2012 - 2022 (USD Billion) 5.2.2 U.S. 5.2.2.1 U.S. market, 2012 - 2022 (USD Billion) 5.2.3 Canada 5.2.3.1 Canada market, 2012 - 2022 (USD Billion) 5.3 Europe 5.3.1 Europe personalized medicine market, 2012 - 2022 (USD Billion) 5.3.2 Germany 5.3.2.1 Germany market, 2012 - 2022 (USD Billion) 5.3.3 UK 5.3.3.1 UK market, 2012 - 2022 (USD Billion) 5.4 Asia Pacific 5.4.1 Asia Pacific personalized medicine market, 2012 - 2022 (USD Billion) 5.4.2 Japan 5.4.2.1 Japan market, 2012 - 2022 (USD Billion) 5.4.3 China 5.4.3.1 China market, 2012 - 2022 (USD Billion) 5.5 Latin America 5.5.1 Latin America personalized medicine market, 2012 - 2022 (USD Billion) 5.5.2 Brazil 5.5.2.1 Brazil market, 2012 - 2022 (USD Billion) 5.6 MEA 5.6.1 MEA personalized medicine market, 2012 - 2022 (USD Billion) 5.6.2 South Africa 5.6.2.1 South Africa market, 2012 - 2022 (USD Billion) Chapter 6 Competitive Landscape 6.1 GE Healthcare 6.1.1 Company Overview 6.1.2 Financial Performance 6.1.3 Product Benchmarking 6.1.4 Strategic Initiatives 6.2 Illumina Incorporated 6.2.1 Company Overview
6.2.2 Financial Performance 6.2.3 Product Benchmarking 6.2.4 Strategic Initiatives 6.3 Asuragen Incorporated 6.3.1 Company Overview 6.3.2 Financial Performance 6.3.3 Product Benchmarking 6.3.4 Strategic Initiatives 6.4 Cepheid 6.4.1 Company Overview 6.4.2 Financial Performance 6.4.3 Product Benchmarking 6.4.4 Strategic Initiatives 6.5 Abbott Laboratories 6.5.1 Company Overview 6.5.2 Financial Performance 6.5.3 Product Benchmarking 6.5.4 Strategic Initiatives 6.6 Dako A/S 6.6.1 Company Overview 6.6.2 Financial Performance 6.6.3 Product Benchmarking 6.6.4 Strategic Initiatives 6.7 Exact Science Corporation 6.7.1 Company Overview 6.7.2 Financial Performance 6.7.3 Product Benchmarking 6.7.4 Strategic Initiatives 6.8 Biogen 6.8.1 Company Overview 6.8.2 Financial Performance 6.8.3 Product Benchmarking 6.8.4 Strategic Initiatives 6.9 Decode Genetics Inc. 6.9.1 Company Overview 6.9.2 Financial Performance 6.9.3 Product Benchmarking 6.9.4 Strategic Initiatives 6.10 Exagen Diagnostics Inc. 6.10.1 Company Overview 6.10.2 Financial Performance 6.10.3 Product Benchmarking 6.10.4 Strategic Initiatives
6.11 Genelex Corporation 6.11.1 Company Overview 6.11.2 Financial Performance 6.11.3 Product Benchmarking 6.11.4 Strategic Initiatives 6.12 Precision Biologics Incorporated 6.12.1 Company Overview 6.12.2 Financial Performance 6.12.3 Product Benchmarking 6.12.4 Strategic Initiatives 6.13 Qiagen Incorporated 6.13.1 Company Overview 6.13.2 Financial Performance 6.13.3 Product Benchmarking 6.13.4 Strategic Initiatives 6.14 Celera Diagnostics 6.14.1 Company Overview 6.14.2 Financial Performance 6.14.3 Product Benchmarking 6.14.4 Strategic Initiatives 6.15 Affymetrix Incorporated 6.15.1 Company Overview 6.15.2 Financial Performance 6.15.3 Product Benchmarking 6.15.4 Strategic Initiatives 6.16 DNA Direct Inc. 6.16.1 Company Overview 6.16.2 Financial Performance 6.16.3 Product Benchmarking 6.16.4 Strategic Initiatives 6.17 Agendia N.V. 6.17.1 Company Overview 6.17.2 Financial Performance 6.17.3 Product Benchmarking 6.17.4 Strategic Initiatives
Browse full report @ http://www.grandviewresearch.com/industry-analysis/personalizedmedicine-market
List of Tables TABLE 1 Personalized Medicine - Industry Snapshot & Key Buying Criteria, 2012 - 2022 TABLE 2 Global personalized medicine market, by application, 2012 - 2022 (USD Billion) TABLE 3 Personalized medicine market, by region, 2012 - 2022 (USD Billion) TABLE 4 Personalized medicine- Key market driver analysis TABLE 5 Global cancer incidences, 2012 TABLE 6 North America cancer incidences in 2012 TABLE 7 Europe cancer incidences, 2012 TABLE 8 Asia cancer incidences, 2012 TABLE 9 Africa cancer incidences, 2012 TABLE 10 Australia and New Zealand cancer incidences in 2012 TABLE 11 Healthcare expenditure levels, 2012 TABLE 12 Personalized medicine- Key market restraint analysis TABLE 13 North America personalized medicine market, by product, 2012- 2022 (USD Billion) TABLE 14 North America PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 15 North America PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 16 North America personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 17 North America personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 18 U.S. personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 19 U.S. PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 20 U.S. PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 21 U.S. personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 22 U.S. personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 23 Canada personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 24 Canada PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 25 Canada PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 26 Canada personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 27 Canada personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 28 Europe personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 29 Europe PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 30 Europe PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 31 Europe personalized medical care market, by product, 2012 - 2022 (USD Billion)
TABLE 32 Europe personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 33 Germany personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 34 Germany PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 35 Germany PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 36 Germany personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 37 Germany personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 38 UK personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 39 UK PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 40 UK PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 41 UK personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 42 UK personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 43 Asia Pacific personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 44 Asia Pacific PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 45 Asia Pacific PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 46 Asia Pacific personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 47 Asia Pacific personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 48 Japan personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 49 Japan PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 50 Japan PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 51 Japan personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 52 Japan personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 53 China personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 54 China PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 55 China PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 56 China personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 57 China personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 58 Latin America personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 59 Latin America PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 60 Latin America PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 61 Latin America personalized medical care market, by product, 2012 - 2022 (USD Billion)
TABLE 62 Latin America personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 63 Brazil personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 64 Brazil PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 65 Brazil PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 66 Brazil personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 67 Brazil personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 68 MEA personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 69 MEA PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 70 MEA PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 71 MEA personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 72 MEA personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion) TABLE 73 South Africa personalized medicine market, by product, 2012 - 2022 (USD Billion) TABLE 74 South Africa PM diagnostics market, by product, 2012 - 2022 (USD Billion) TABLE 75 South Africa PM therapeutics market, by product, 2012 - 2022 (USD Billion) TABLE 76 South Africa personalized medical care market, by product, 2012 - 2022 (USD Billion) TABLE 77 South Africa personalized nutrition & wellness market, by product, 2012 - 2022 (USD Billion)
For More Information visit http://www.grandviewresearch.com/industryanalysis/personalized-medicine-market
List of Figures FIG. 1 Personalized medicine: Market segmentation FIG. 2 Global personalized medicine market, 2012 - 2022 (USD Billion) FIG. 3 Personalized medicine: Market dynamics FIG. 4 Key opportunities prioritized - PM diagnostics & PM therapeutics, 2014 FIG. 5 Key opportunities prioritized - PM medical care & PM nutrition, 2014 FIG. 6 Personalized medicine market - Porter’s analysis FIG. 7 Personalized medicine market - PESTEL analysis FIG. 8 Personalized medicine - application opportunity v/s implementation, 2014 - 2022 FIG. 9 Personalized medicine - Application opportunities prioritized, 2014 - 2022 FIG. 10 Personalized medicine revenue share, by product, 2014 & 2022 FIG. 11 PM diagnostics market, 2012 - 2022 (USD Billion)
FIG. 12 Genetic testing market , 2012 - 2022 (USD Billion) FIG. 13 DTC diagnostics market , 2012 - 2022 (USD Billion) FIG. 14 Esoteric lab services market , 2012 - 2022 (USD Billion) FIG. 15 Esoteric lab tests market , 2012 - 2022 (USD Billion) FIG. 16 PM therapeutics market, 2012 - 2022 (USD Billion) FIG. 17 Pharmaceuticals market , 2012 - 2022 (USD Billion) FIG. 18 Genomic medicine market , 2012 - 2022 (USD Billion) FIG. 19 Medical devices market , 2012 - 2022 (USD Billion) FIG. 20 Personalized medical care market, 2012 - 2022 (USD Billion) FIG. 21 Telemedicine market , 2012 - 2022 (USD Billion) FIG. 22 Health information technology market , 2012 - 2022 (USD Billion) FIG. 23 Disease management market , 2012 - 2022 (USD Billion) FIG. 24 Personalized nutrition & wellness market, 2012 - 2022 (USD Billion) FIG. 25 Retail nutrition market , 2012 - 2022 (USD Billion) FIG. 26 Complementary medicine market , 2012 - 2022 (USD Billion) FIG. 27 Alternative medicine market , 2012 - 2022 (USD Billion) FIG. 28 Global personalized medicine market share, by region, 2014& 2022 FIG. 29 North America personalized medicine market, 2012 - 2022 (USD Billion) FIG. 30 U.S. personalized medicine market, 2012 - 2022 (USD Billion) FIG. 31 Canada personalized medicine market, 2012 - 2022 (USD Billion) FIG. 32 Europe personalized medicine market, 2012 - 2022 (USD Billion) FIG. 33 Germany personalized medicine market, 2012 - 2022 (USD Billion) FIG. 34 UK personalized medicine market, 2012 - 2022 (USD Billion) FIG. 35 Asia Pacific personalized medicine market, 2012 - 2022 (USD Billion) FIG. 36 Japan personalized medicine market, 2012 - 2022 (USD Billion) FIG. 37 China personalized medicine market, 2012 - 2022 (USD Billion) FIG. 38 Latin America personalized medicine market, 2012 - 2022 (USD Billion) FIG. 39 Brazil personalized medicine market, 2012 - 2022 (USD Billion) FIG. 40 MEA personalized medicine market, 2012 - 2022 (USD Billion) FIG. 41 South Africa personalized medicine market, 2012 - 2022 (USD Billion)
Further key findings from the study suggest: 
Personalized nutrition and wellness was the largest product segment of the market in 2014. Growing population considerably high market usage and high accessibility are amongst key factors accounting for its large share. Moreover, the core segments of this market viz., personalized medicine diagnostics and therapeutics are expected to grow at the fastest rate over the forecast period due to, ongoing technological advancements in genetic medicine.
North America was the largest regional market in 2014, with revenue estimated at over USD 500.0 billion. Presence of sophisticated healthcare infrastructure, favorable government initiatives pertaining to cancer research, and the presence of high patient and practitioner awareness levels are some key drivers of this market. Asia Pacific is expected to witness lucrative growth of over 13.0% over the forecast period. The presence of a large population base, high market penetration of segments such as complementary and alternative medicine, growing collaborative initiatives between western and eastern market participants are some key factors expected to drive regional market growth over the forecast period. Key players of this market include GE Healthcare, Illumina Inc., Quest Diagnostics, Abbott Diagnostics, Affymetrix, and Bayer Healthcare. Large presence of biotechnology and pharmaceutical manufacturers is expected to keep the industry rivalry at high levels throughout the forecast period. Moreover, the presence of extensive R&D to capitalize on novel growth opportunities is expected to further intensify competition over the forecast period.
Request free sample of this Report @ http://www.grandviewresearch.com/industryanalysis/personalized-medicine-market/request
For the purpose of this study, Grand View Research has segmented the global personalized medicine market on the basis of product and region: Global Personalized Medicine Product Outlook (Revenue, USD Billion, 2012 – 2022)
PM Diagnostics Genetic Testing Direct-to-consumer Diagnostics Esoteric Lab Services Esoteric Lab Tests PM Therapeutics Pharmaceutical Genomic Medicine Medical Devices Personalized Medical Care Telemedicine Healthcare Information Technology Diseases Management Personalized Nutrition & Wellness Retail Nutrition Complementary Medicine Alternative Medicine
Personalized Medicine Regional Outlook (Revenue, USD Billion, 2012 – 2022)
North America U.S. Canada
Europe
Germany UK Asia Pacific China Japan Latin America Brazil MEA South Africa
Browse
All
Reports
of
this
category
@
http://www.grandviewresearch.com/industry/biotechnology
About Grand View Research Grand View Research, Inc. is a market research and consulting company that provides off-theshelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deepseated understanding of varied business environments, Grand View Research provides strategic objective insights.
Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States Phone: 1-415-349-0058
Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Website: Grand View Research Blog Site: http://www.divog.org/